Urinary Biomarkers of Oxidative Stress in Aging: Implications for Prediction of Accelerated Biological Age in Prospective Cohort Studies.


Journal

Oxidative medicine and cellular longevity
ISSN: 1942-0994
Titre abrégé: Oxid Med Cell Longev
Pays: United States
ID NLM: 101479826

Informations de publication

Date de publication:
2022
Historique:
received: 28 10 2021
revised: 05 03 2022
accepted: 28 03 2022
entrez: 16 5 2022
pubmed: 17 5 2022
medline: 20 5 2022
Statut: epublish

Résumé

Aging is a major risk factor for a range of chronic diseases. Oxidative stress theory of aging has been previously proposed as one of the mechanisms responsible for the age-related decline in organ/tissue function and the development of age-related diseases. Urine contains rich biological information on the health status of every major organ system and can be an important noninvasive source for biomarkers of systemic oxidative stress in aging. The objective of this cross-sectional study was to validate a novel panel of urinary oxidative stress biomarkers. Nucleic acid oxidation adducts and oxidative damage markers of lipids and proteins were assessed in urine samples from nondiabetic and currently nonsmoking subjects ( Our findings showed that 8-oxo-7,8-deoxyguanosine (8-oxoG), 8-oxo-7,8-dihydroguanosine (8-OHdG), and dityrosine (DTyr) positively correlated with chronological age, while the level of an F Assessing urinary biomarkers of oxidative stress may be an important approach for the evaluation of biological age by identifying individuals at accelerated risk for the development of age-related diseases.

Sections du résumé

Background UNASSIGNED
Aging is a major risk factor for a range of chronic diseases. Oxidative stress theory of aging has been previously proposed as one of the mechanisms responsible for the age-related decline in organ/tissue function and the development of age-related diseases. Urine contains rich biological information on the health status of every major organ system and can be an important noninvasive source for biomarkers of systemic oxidative stress in aging.
Aims UNASSIGNED
The objective of this cross-sectional study was to validate a novel panel of urinary oxidative stress biomarkers.
Methods UNASSIGNED
Nucleic acid oxidation adducts and oxidative damage markers of lipids and proteins were assessed in urine samples from nondiabetic and currently nonsmoking subjects (
Results UNASSIGNED
Our findings showed that 8-oxo-7,8-deoxyguanosine (8-oxoG), 8-oxo-7,8-dihydroguanosine (8-OHdG), and dityrosine (DTyr) positively correlated with chronological age, while the level of an F
Conclusion UNASSIGNED
Assessing urinary biomarkers of oxidative stress may be an important approach for the evaluation of biological age by identifying individuals at accelerated risk for the development of age-related diseases.

Identifiants

pubmed: 35571254
doi: 10.1155/2022/6110226
pmc: PMC9106456
doi:

Substances chimiques

Biomarkers 0
Deoxyguanosine G9481N71RO

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6110226

Subventions

Organisme : NIGMS NIH HHS
ID : U54 GM104938
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG068295
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG050911
Pays : United States
Organisme : Medical Research Council
ID : MR/S011676/1
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA255840
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103447
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG052363
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG055395
Pays : United States
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : P20 GM125528
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS100782
Pays : United States

Informations de copyright

Copyright © 2022 Peter Mukli et al.

Déclaration de conflit d'intérêts

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Références

Clin Chim Acta. 2012 Oct 9;413(19-20):1446-53
pubmed: 22683781
Cell. 2014 Nov 6;159(4):709-13
pubmed: 25417146
Front Aging Neurosci. 2018 Feb 27;10:34
pubmed: 29535624
Geroscience. 2020 Apr;42(2):727-748
pubmed: 32172434
J UOEH. 2013 Jun 1;35(2):119-27
pubmed: 23774655
Aging Dis. 2020 Oct 1;11(5):1329-1338
pubmed: 33014540
Free Radic Biol Med. 2003 Nov 15;35(10):1301-9
pubmed: 14607529
Gerontology. 1991;37(1-3):166-80
pubmed: 2055497
FASEB Bioadv. 2020 Oct 21;2(12):720-733
pubmed: 33336159
Clin Interv Aging. 2017 May 11;12:759-772
pubmed: 28546743
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4104-10
pubmed: 26150497
Clin Interv Aging. 2018 Apr 26;13:757-772
pubmed: 29731617
J Gerontol. 1956 Jul;11(3):298-300
pubmed: 13332224
Atherosclerosis. 2006 Feb;184(2):425-30
pubmed: 15996671
Mech Ageing Dev. 2006 Mar;127(3):240-8
pubmed: 16318865
Biogerontology. 2005;6(4):283-90
pubmed: 16333762
J Am Coll Cardiol. 2020 Mar 3;75(8):931-941
pubmed: 32130929
EBioMedicine. 2017 Jul;21:29-36
pubmed: 28396265
Redox Biol. 2013 Oct 08;1:483-91
pubmed: 24251116
Redox Biol. 2017 Aug;12:582-599
pubmed: 28391180
Physiol Int. 2021 Jan 06;107(4):479-490
pubmed: 33410768
Biogerontology. 2020 Oct;21(5):531-548
pubmed: 32274599
Geroscience. 2019 Dec;41(6):711-725
pubmed: 31654270
Free Radic Biol Med. 2003 Feb 15;34(4):409-18
pubmed: 12566066
Nutrients. 2020 Sep 23;12(10):
pubmed: 32977370
Aging (Albany NY). 2021 May 19;13(10):14322-14341
pubmed: 34016789
Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5360-3
pubmed: 2052612
Elife. 2020 Feb 11;9:
pubmed: 32041686
Geroscience. 2019 Dec;41(6):727-738
pubmed: 31655958
Antioxid Redox Signal. 2015 Nov 10;23(14):1144-70
pubmed: 26415143
Elife. 2020 May 05;9:
pubmed: 32367804
Biogerontology. 2020 Dec;21(6):731-744
pubmed: 32632778
Biogerontology. 2021 Apr;22(2):165-187
pubmed: 33502634
Age (Dordr). 2008 Sep;30(2-3):121-33
pubmed: 19424862
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Diabetologia. 2009 Sep;52(9):1935-43
pubmed: 19597800
Geroscience. 2019 Oct;41(5):533-542
pubmed: 31679124
Redox Biol. 2019 Jun;24:101192
pubmed: 31015147
Circ Res. 2018 Sep 14;123(7):849-867
pubmed: 30355080
J Gerontol A Biol Sci Med Sci. 2013 Jun;68(6):667-74
pubmed: 23213031
Oxid Med Cell Longev. 2018 Aug 23;2018:1743253
pubmed: 30210648
Geroscience. 2019 Oct;41(5):609-617
pubmed: 31643012
Geroscience. 2020 Apr;42(2):527-546
pubmed: 32056076
Proc Natl Acad Sci U S A. 1990 Dec;87(23):9383-7
pubmed: 2123555

Auteurs

Peter Mukli (P)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Department of Physiology, Semmelweis University, Budapest, Hungary.

Dee H Wu (DH)

Department of Radiological Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Tamas Csipo (T)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.

Cameron D Owens (CD)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Agnes Lipecz (A)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.

Frigyes Samuel Racz (FS)

Department of Physiology, Semmelweis University, Budapest, Hungary.
Department of Neurology, Dell Medical School, University of Texas at Austin, Austin, TX, USA.

Fouad A Zouein (FA)

The Cardiovascular, Renal, and Metabolic Diseases Research Center of Excellence, American University of Beirut Medical Center, Riad El-Solh, Beirut, Lebanon.
Department of Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Inserm, Université Paris-Saclay, France.
Department of Pharmacology and Toxicology, School of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.

Adam Tabak (A)

International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.
1st Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary.

Anna Csiszar (A)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Translational Medicine, Semmelweis University, Budapest, Hungary.

Zoltan Ungvari (Z)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Department of Radiological Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.
Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Panayiotis D Tsitouras (PD)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Andriy Yabluchanskiy (A)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH